Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene

Molecular Medicine

Volumn 3, Issue 7, 1997, Pages 441-451

  Wu, Lin ^a   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS INHIBITION; DRUG MEGADOSE; GENETIC REGULATION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

EID: 0030881590     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401691     Document Type: Article

References (30)

1. Cahilly-Snyder L, Yang-Feng T, Francke U, George DL. (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Sem. Cell Molec. Gen. 13: 235-244.
2. Oliner JD, Kinzler KW, Meltzer PS, George D, Vogelstein B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
3. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B. (1993) P53 mutations and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53: 2231-2234.
4. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18.
5. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. (1993) The human MDM-2 oncogene is overexpressed in leukemias. Blood 82: 2617-2623.
6. Sheikh MS, Shao AM, Hussain A, Fontana JA. (1993) The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res. 53: 3226-3228.
7. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murate T, Saito H. (1994) The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of β-cell origin. Blood 84: 3158-3165.
8. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53: 2736-2739.
9. Fakharzadeh SS, Trusko SP, George DL. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569.
10. Finlay CA. (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306.
11. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69: 1237-1245.
12. Barak Y, Oren M. (1992) Enhanced binding of a 95 Kd protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11: 2115-2121.
13. Chen J, Lin J, Levine AJ. (1995) The regulation of p53-mediated transcription functions by mdm-2. Mol. Med. 1: 142-152.
14. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
15. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace, Jr. AJ. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
16. Miyashita T, Krajewski S, Krajewska M, Wang H-K, Lieberman D, Hoffman B, Reed J. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
17. Murphy M, Hinman A, Levine AJ. (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes & Development 10: 2971-2980.
18. Wu X, Bayle JH, Olson D, Levine AJ. (1993) The p53-mdm-2 autoregulatory feedback loop. 17: 1126-1132.
19. Juven T, Barak Y, Zauberman A, George DL, Oren M. (1993) Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8: 3411-3416.
20. Chen JD, Wu XW, Lin JY, Levine AJ. (1996) mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Bio. 16: 2445-2452.
21. Montes de Oca Luna R, Wagner DS, Lozano G. (1995) Rescue of early embroynic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
22. Jones SN, Roe AE, Donehower LA, Bradley A. (1995) Rescue of embroynic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
23. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
24. Lu X, Lane DP. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778.
25. Perry ME, Piette J, Zawadzki J, Harvey D, Levine AJ. (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90: 11623-11627.
26. Chen CY, Oliner JD, Zhan Q, Fornace AJJ, Vogelstein B, Kastan MB. (1994) Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA 91: 2684-2688.
27. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. (1989) Current Protocols in Molecular Biology, Vol. 1. Greene Publishing Associates and Wiley-Interscience, New York.
28. Xiao ZX, Chen JD, Levine AL, Moditahedi N, Xing J, Sellers WR, Livingston DM. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698.
29. Martin K, Trouche D, Hagemeler C, Sørensen TS, La Thangue NB, Kouzarides T. (1995) Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 375: 691-694.
30. Barak Y, Gottlieb E, Juven-Gershon T, Oren M. (1994) Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential. Genes & Dev. 8: 1739-1749.